H-CYTE, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.09 million compared to USD 3.89 million a year ago. Basic loss per share from continuing operations was USD 3.38 compared to USD 23.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0036 USD | -34.55% |
|
0.00% | -96.90% |
1st Jan change | Capi. | |
---|---|---|
-96.90% | 19.22T | |
+4.18% | 21TCr | |
+8.00% | 19TCr | |
+31.86% | 16TCr | |
+33.21% | 11TCr | |
+2.28% | 6.43TCr | |
+21.14% | 5.57TCr | |
+0.11% | 4.84TCr | |
-6.76% | 3.78TCr | |
+0.78% | 3.56TCr |
- Stock Market
- Equities
- IVRN Stock
- News Innoveren Scientific Inc.
- H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023